Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Ethnopharmacol ; 135(1): 179-85, 2011 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-21396999

RESUMO

AIM OF THE STUDY: To evaluate the protective effect of baicalein on myocardial dysfunction caused by endotoxaemia in rats and to explore the possible mechanisms. MATERIALS AND METHODS: Baicalein (10mg/kg, intravenous) was administered to conscious Wistar rats 30min after lipopolysaccharide (LPS; 10mg/kg, intravenous) challenge. Six hours after LPS administration, the contractile function of the isolated heart was examined using the Langendorff technique. Cardiac protein expression related to inflammatory responses, superoxide anion production and caspase-3 activity were measured. RESULTS: Post-treatment with baicalein significantly attenuated the LPS-induced hypotension with accompanying tachycardia. The contractile function of isolated heart was significantly preserved 6h after LPS administration, following treatment with baicalein. Furthermore, baicalein induced the expression of heme oxygenase-1 protein and reduced superoxide anion formation in the myocardium of LPS-treated rats. Cardiac levels of inducible nitric oxide synthase, monocyte chemoattractant protein-1, phospho-IκBα and phospho-p65 protein and caspase-3 activity significantly increased 6h after LPS challenge but baicalein significantly attenuated these LPS-induced changes. CONCLUSIONS: Baicalein improves myocardial contractility in LPS-induced sepsis, which may be related to reductions in oxidative stress, myocardial inflammatory responses and apoptosis.


Assuntos
Anti-Inflamatórios/uso terapêutico , Endotoxemia/tratamento farmacológico , Flavanonas/uso terapêutico , Coração/efeitos dos fármacos , Heme Oxigenase (Desciclizante)/metabolismo , Fitoterapia , Scutellaria baicalensis/química , Animais , Anti-Inflamatórios/farmacologia , Caspase 3/metabolismo , Quimiocina CCL2/metabolismo , Endotoxemia/metabolismo , Endotoxemia/fisiopatologia , Flavanonas/farmacologia , Coração/fisiopatologia , Hipotensão/induzido quimicamente , Hipotensão/tratamento farmacológico , Proteínas I-kappa B/metabolismo , Inflamação/induzido quimicamente , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Lipopolissacarídeos , Masculino , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Miocárdio/metabolismo , Inibidor de NF-kappaB alfa , Proteínas de Neoplasias/metabolismo , Óxido Nítrico Sintase Tipo II/metabolismo , Proteínas de Transporte Nucleocitoplasmático/metabolismo , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ratos , Ratos Wistar , Superóxidos/metabolismo , Taquicardia/induzido quimicamente , Taquicardia/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA